J P R Pelletier

J P R Pelletier, M.D., FCAP, FASCP

Director, Transfusion Services

Department: MD-PATHOLOGY-GENERAL
Business Email: pelletierp@ufl.edu

About J P R Pelletier

J. PETER R. PELLETIER MD, FCAP, FASCP

Dr Joseph Peter R. Pelletier is Medical Director of Transfusion Services at Shands UF Blood Bank; He also holds an appointment as Associate Clinical Professor in the Department of Pathology, Immunology and Laboratory Medicine and Anesthesia.

Dr Pelletier was a Medical Technologist graduating from University of Connecticut before entering Medical School at University of Health Sciences/The Chicago Medical School. He did internal medicine Residency at Wright-Patterson In Dayton Ohio and Practice 3 years at Tinker AFB in OK. He entered Anatomic /Clinical Pathology Residency at Wilford Hall Medical Center before completing a Blood Bank Fellowship at Yale New Haven Hospital. He is board certified in these 4 specialties.

Dr Pelletier is a retired AF Colonel with 23 years of service. He held AF appointment as Consultant to AF/SG in Pathology and Transfusion Medicine. He was also the Department of Defense representative to the HHS Advisory Council on Blood and Tissue Safety and Availability. He was also awarded Grand Master Status in Anatomic and Clinical Pathology. He joined UF on 1 September 2014.

As Medical Director Transfusion Service Dr Pelletier responsible for ensuring the Quality Assurance and Control plan is carried out in an appropriate manner for the blood bank. Medical Director provides continuous feedback to the Manager and other technical staff in order to provide better patient care and meet the needs of patients and customers. Medical Director provides clinical consultation to medical staff and intervene in complex quality or patient care issues. Medical Director provides guidance and direction in the selection of instruments, test, methods, kits and computer software. Medical Director is required to review and approve validation of instrumentation or software, new and revised procedures as well as evaluating and determining the type of blood products will be made available for the patient. Medical Director is responsible for overseeing the implementation and adherence to the quality program. This is to include periodic monitoring and review of quality documents (Proficiency Testing, Incident /Variance reports, SUF Quality Improvement Reports, Patient Safety Reports for SUF and Transfusion Committee Dashboard Reports.

Dr Pelletier’s research interests are in the areas of Pathogen reduction/inactivation, massive transfusion protocols’ blood program management/utilization, treatment of infectious disease with passive immunization, and use of alternative blood.

Accomplishments

Hospital Donor Group Achievement Award
2015 · Florida Association of Blood Bankers
DoD representative
2012-2014 · HHS Advisory Committee for Blood Safety and Availability
59 MDW Chief Pathology Consultant
2010-2014 · AF/SG
AF Pathology Consultant
2010-2014 · Center for Clinical Laboratory Medicine
Co- Chairman And Air Force Pathology Consultant
2010-2014 · DoD Laboratory Joint Working Group
Faculty
2010-2014 · Emergency War Surgery Course
Member
2010-2014 · Department of Defense Laboratory network
Voting Member of the Board
2010-2014 · Board of Directors, SAFMLS
AF Transfusion Medicine Consultant
2006-2014 · ASBPO

Teaching Profile

Courses Taught
2020
BMS6631 Hematology

Board Certifications

  • Pathology – Anatomic and Clinical
    American Board of Pathology
  • Pathology – Blood banking/Transfusion Medicine
    American Board of Pathology

Clinical Profile

Subspecialties
  • Blood Banking
  • Clinical Pathology
Areas of Interest
  • Extracorporeal membrane oxygenation
  • Placenta previa
  • Transplant services
  • Traumatic Injury

Research Profile

Open Researcher and Contributor ID (ORCID)

0000-0002-2320-3180

Publications

2022
Adding Automation and Independent Dual Verification to Reduce Wrong Blood in Tube (WBIT) Events
American Journal of Clinical Pathology. [DOI] 10.1093/ajcp/aqac031.
2019
Anti-N and anti-Doa immunoglobulin G alloantibody-mediated delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease treated with eculizumab and HBOC-201: case report and review of the literature.
Transfusion. 59(6):1907-1910 [DOI] 10.1111/trf.15198. [PMID] 30768787.
2019
Packed red blood cell donor age affects overall survival in transfused patients undergoing hepatectomy for non-hepatocellular malignancy.
American journal of surgery. 217(1):71-77 [DOI] 10.1016/j.amjsurg.2018.08.011. [PMID] 30172359.

Education

Fellowship – Blood banking/Transfusion Medicine
2005 · Yale University
Residency – Pathology – Anatomic and clinical
2001 · San Antonio Uniform Services Health Education Consortium
Residency – Internal Medicine
1994 · US Air Force Medical Center, Wright-Patterson
Internship – Internal Medicine
1992 · US Air Force Medical Center, Wright-Patterson
Medical Degree
1991 · Rosalind Franklin University of Medicine and Science

Contact Details

Emails:
Business:
pelletierp@ufl.edu
Addresses:
Business Mailing:
DEPT OF PATHOLOGY, IMMUNLOGY AND LABORATORY
PO BOX 100275
UF HEALTH
GAINESVILLE FL 326100275
Business Street:
DEPT OF PATHOLOGY, IMMUNOLOGY AND LABORATORY
1600 SW ARCHER RD RM 3110
UF HEALTH
GAINESVILLE FL 326103003